These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19203568)

  • 1. Status epilepticus in a patient treated with olanzapine and mirtazapine.
    Spyridi S; Sokolaki S; Nimatoudis J; Iacovides A; Kaprinis G
    Int J Clin Pharmacol Ther; 2009 Feb; 47(2):120-3. PubMed ID: 19203568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [FOCAL MOTOR SEIZURES AND STATUS EPILEPTICUS PROVOKED BY MIRTAZAPINE].
    Dömötör J; Clemens B
    Ideggyogy Sz; 2015 Jul; 68(7-8):286-8. PubMed ID: 26380424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal status epilepticus associated with olanzapine therapy.
    Wyderski RJ; Starrett WG; Abou-Saif A
    Ann Pharmacother; 1999; 33(7-8):787-9. PubMed ID: 10466904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of anorexia with a combination of high-dose olanzapine, fluoxetine and mirtazapine.
    Fountoulakis KN; Iacovides A; Siamouli M; Koumaris V; Kaprinis GS
    Int J Clin Pharmacol Ther; 2006 Sep; 44(9):452-3. PubMed ID: 16995335
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin syndrome and atypical antipsychotics.
    Duggal HS; Fetchko J
    Am J Psychiatry; 2002 Apr; 159(4):672-3. PubMed ID: 11925312
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study.
    Loonen AJ; Doorschot CH; Oostelbos MC; Sitsen JM
    Eur Neuropsychopharmacol; 1999 Dec; 10(1):51-7. PubMed ID: 10647097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-refractory depression successfully treated with the combination of mirtazapine and lithium.
    Moustgaard G
    J Clin Psychopharmacol; 2000 Apr; 20(2):268. PubMed ID: 10770470
    [No Abstract]   [Full Text] [Related]  

  • 8. Mirtazapine add-on improves olanzapine effect on negative symptoms of schizophrenia.
    Caforio G; Di Giorgio A; Rampino A; Rizzo M; Romano R; Taurisano P; Fazio L; De Simeis G; Ursini G; Blasi G; Nardini M; Mancini M; Bertolino A
    J Clin Psychopharmacol; 2013 Dec; 33(6):810-2. PubMed ID: 24113675
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine-induced myoclonic status.
    Camacho A; García-Navarro M; Martínez B; Villarejo A; Pomares E
    Clin Neuropharmacol; 2005; 28(3):145-7. PubMed ID: 15965316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone.
    Zink M; Knopf U; Argiriou S; Kuwilsky A
    J Clin Psychiatry; 2006 May; 67(5):835. PubMed ID: 16841636
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electroconvulsion therapy for neuroleptic malignant syndrome].
    Buggenhout S; Vandenberghe J; Sienaert P
    Tijdschr Psychiatr; 2014; 56(9):612-5. PubMed ID: 25222100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial.
    Michelson D; Kociban K; Tamura R; Morrison MF
    J Psychiatr Res; 2002; 36(3):147-52. PubMed ID: 11886692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotic-induced akathisia with depression: therapeutic role of mirtazapine.
    Ranjan S; Chandra PS; Chaturvedi SK; Prabhu SC; Gupta A
    Ann Pharmacother; 2006 Apr; 40(4):771-4. PubMed ID: 16569791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertriglyceridemia, acute pancreatitis, and diabetic ketoacidosis possibly associated with mirtazapine therapy: a case report.
    Chen JL; Spinowitz N; Karwa M
    Pharmacotherapy; 2003 Jul; 23(7):940-4. PubMed ID: 12885107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment of olanzapine and mirtazapine in anorexia nervosa associated with major depression.
    Wang TS; Chou YH; Shiah IS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):306-9. PubMed ID: 16314020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal agranulocytosis associated with psychotropic medication use.
    Nazer LH; Shankar G; Ali BA; Al-Najjar T
    Am J Health Syst Pharm; 2012 May; 69(10):863-7. PubMed ID: 22555081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirtazapine-induced hepatotoxicity.
    Hui CK; Yuen MF; Wong WM; Lam SK; Lai CL
    J Clin Gastroenterol; 2002 Sep; 35(3):270-1. PubMed ID: 12192206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLMD-like nocturnal movements with mirtazapine.
    Mattoo SK; Mahajan S; Sarkar S; Nebhinani N
    Gen Hosp Psychiatry; 2013; 35(5):576.e7-8. PubMed ID: 23273829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
    Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe rhabdomyolysis induced by quetiapine and mirtazapine in a French military soldier.
    Saguin E; Keou S; Ratnam C; Mennessier C; Delacour H; Lahutte B
    J R Army Med Corps; 2018 May; 164(2):127-129. PubMed ID: 29632134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.